Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2032

Conditions
Breast CancerCancer of BreastBreast NeoplasmsCancer of the Breast
Interventions
BEHAVIORAL

FACT-B

The FACT-B (Version 4) is a 37-item measure that contains the four general subscales along with the Breast Cancer-Specific subscale that assesses symptoms/concerns of particular relevance to breast cancer (e.g., body image, arm swelling and tenderness).

DRUG

Goserelin

DRUG

Anastrozole

DRUG

Exemestane

DRUG

Fulvestrant

DRUG

Tamoxifen

OTHER

Archived tissue collection

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genomic Health®, Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT02476786 - Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score | Biotech Hunter | Biotech Hunter